PofoliaShared via Pofolia

Antioxidants· 2026Q1

Glucocorticoid Consumption Alters Selenium Homeostasis and Hippocampal Selenoprotein Levels

Jessica L. Nicholson, Yujia Qin, Mark F. Boktor, Christine N. S. C. Lau et al.

Short summary

Long-term glucocorticoid administration in mice alters hippocampal selenoprotein levels, potentially by disrupting selenium distribution to the brain.

AI-generated from the title and abstract; the full text is not read.

Key points

  • Glucocorticoids alter levels of Glutathione peroxidase 1 and Selenoprotein S in the hippocampus.
  • These alterations are dependent on selenium availability and receptor activation (glucocorticoid and mineralocorticoid receptors).
  • Spatial transcriptomic analysis indicates cell-specific changes in selenoprotein gene expression within the hippocampus.
  • Glucocorticoids may indirectly decrease brain selenoprotein levels by limiting selenium distribution to the brain.

AI-generated from the title and abstract; the full text is not read.

Abstract

Long-term elevation of glucocorticoid levels is detrimental to neurological function, causing disturbances in mood and memory. Multiple molecular mechanisms of action have been implicated, including the disruption of antioxidant defense systems. This study focused on the impact of glucocorticoids on selenoproteins, which include selenoenzymes with antioxidant functions, some of which are essential for proper brain function. We exposed C57/BL6 mice to long-term glucocorticoid administration and measured changes in selenoprotein levels and gene expression. To study the underlying mechanism of selenoprotein regulation, we used an immortalized mouse hippocampal cell line. We found that Glutathione peroxidase 1 and Selenoprotein S levels are altered by glucocorticoids in a manner that is dependent on selenium availability and differential activation of the glucocorticoid and mineralocorticoid receptors. Spatial transcriptomic analysis of mouse hippocampal sections suggests spatial and cell-specific changes to the selenoprotein transcriptome. Finally, brain selenoprotein levels may be indirectly decreased by glucocorticoids due to insufficient distribution of selenium to the brain. Thus, glucocorticoids demonstrate an ability to control selenoprotein levels both by acting directly on hippocampal cells as well as indirectly by disrupting the delivery of dietary selenium to the brain. Future work will determine the impact of selenium intake on glucocorticoid-induced neurological dysfunction and damage.

The authors' abstract, as published at the source. Antioxidants, 2026 · DOI ↗

TakeawaysPremium
Ask the paperFree account

Continue with a free account

Ask the paper: 3 free questions a day about this paper; save it, get its citation, new summaries every day for your field. Takeaways are Premium.

Continue free on the web

Sign in with Google or Apple; no card needed. You come back to this paper.

On your phone:

Field: Nutrition and Dietetics

Nutrition and DieteticsNursing